Nasal Cavity and Paranasal Sinus Cancer

  • Chien Peter Chen
  • Brian Missett
  • Sue S. Yom


Maxillary cancers are most common (70%). Incidence higher in Japan and South Africa. More common in males (4:1). Ohngren’s line runs from the medial canthus to the angle of the mandible. Histology: most common is SCC. Adenoid cystic, esthesioneuroblastoma, plasmacytoma, lymphoma, melanoma, and sarcoma also seen. Lymphatic drainage of maxillary antrum to submandibular, parotid, jugulodigastric, retropharyngeal, and jugular nodes. See Chap. 12 for more information on esthesioneuroblastoma.


Nasal Cavity Maxillary Antrum Medial Canthus Sinonasal Cancer Jugular Node 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.



We thank Dr. M. Kara Bucci for her contribution to this chapter in the first edition.



  1. Allen MW, Schwartz DL, Rana V, et al. Long-term radiotherapy outcomes for nasal cavity and septal cancers. Int J Radiat Oncol Biol Phys 2008;71: 401-406.PubMedCrossRefGoogle Scholar
  2. Bernier J, Cooper JS, Pajak TF, et al. Defining risk levels in locally advanced head and neck cancers: a comparative analysis of concurrent postoperative radiation plus chemotherapy trials of the EORTC (#22931) and RTOG (# 9501). Head Neck. 2005;27(10):843-850.PubMedCrossRefGoogle Scholar
  3. Bernier J, Domenge C, Ozsahin M, et al. Postoperative irradiation with or without concomitant chemotheraphy for locally advanced head and neck cancer: N Engl J Med 2004;350:1945-1952PubMedGoogle Scholar
  4. Bristol IJ, Ahamad, A., Garden AS, et al. Postoperative radiotherapy for maxillary sinus cancer: long-term outcomes and toxicities of treatment. Int J Radiat Oncol Biol Phys 2007;68:719-730.PubMedCrossRefGoogle Scholar
  5. Chen AM, Daly ME, Bucci MK, et al. Carcinomas of the paranasal sinuses and nasal cavity treated with radiotherapy at a single institution over five decades: are we making improvement? Int J Radiat Oncol Biol Phys 2007;69:141-147.PubMedCrossRefGoogle Scholar
  6. Dulguerov P, Jacobsen MS, Allal AS, et al. Nasal and paranasal sinus carcinoma: are we making progress? A series of 220 patients and a systematic review. Cancer 2001;92:3012-3029.PubMedCrossRefGoogle Scholar
  7. Le QT, Fu KK, Kaplan MJ, et al. Lymph node metastasis in maxillary sinus carcinoma. Int J Radiat Oncol Biol Phys 2000;46:541-549.PubMedCrossRefGoogle Scholar
  8. Madani I, Bonte K, Vakaet L, et al. Intensity-modulated radiotherapy for sinonasal tumors: Ghent University Hospital update. Int J Radiat Oncol Biol Phys 2009 73:424-432.PubMedCrossRefGoogle Scholar
  9. Snyers A, Janssens GO, Twickler MB, et al. Malignant tumors of the nasal cavity and paranasal sinuses: long-term outcome and morbidity with emphasis on hypothalamic-pituitary deficiency. Int J Radiat Oncol Biol Phys 2009;73:1343-1351.PubMedCrossRefGoogle Scholar

Further Reading

  1. Ahamad A, Ang KK. Nasal Cavity and Paranasal Sinuses. In: Halperin EC, Perez CA, Brady LW, et al., editors. Principles and Practice of Radiation Oncology. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2008. pp. 858-873.Google Scholar
  2. National Cancer Institute. Paranasal Sinus and Nasal Cavity Cancer (PDQ): Treatment. Available at: Accessed on May 11, 2009.
  3. National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology: Head and Neck Cancers. Available at: Accessed on May 11, 2009.
  4. Nguyen L, Ang KK. The Nasal Fossa and Paranasal Sinuses. In: Cox JD, Ang KK, editors. Radiation Oncology: Rationale, Technique, Results. 8th ed. St. Louis: Mosby; 2003. pp. 160-177.Google Scholar
  5. Ryu JK. Cancer of the Nasal Cavity and Paranasal Sinuses. In: Leibel SA, Phillips TL, editors. Textbook of Radiation Oncology. 2nd ed. Philadelphia: Saunders; 2004. pp. 731-756.Google Scholar

Copyright information

© Springer-Verlag New York 2010

Authors and Affiliations

  • Chien Peter Chen
    • 1
  • Brian Missett
    • 2
  • Sue S. Yom
    • 1
  1. 1.Radiation OncologyUniversity of California San FranciscoSan FranciscoUSA
  2. 2.Radiation OncologyKaiser Permanente Santa ClaraSanta ClaraUSA

Personalised recommendations